This inventor holds 1 USPTO granted patent. Top assignee: Lymphact—lymphocyte Activation Technologies, S.a.. Active years: 2021.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2021
Title: Innovator Spotlight: Anfonso Rocha Martins De Almeida
Introduction
Anfonso Rocha Martins De Almeida is a notable inventor hailing from Cantanhede, Portugal. With a keen focus on advancing medical technologies, Anfonso has made significant contributions through her innovative work in immunology and cell therapy.
Latest Patents
Anfonso holds one patent titled "Methods for the production of TCRγδT cells." This invention introduces novel methods for the isolation and selective ex vivo expansion of Vδ2TCRγδT cells, highlighting their clinical applications. This innovative approach promises to enhance therapeutic strategies in immunology.
Career Highlights
Currently, Anfonso is employed at Lymphact - Lymphocyte Activation Technologies, S.A., a company dedicated to developing groundbreaking therapies using lymphocyte activation. Her work contributes to the evolution of treatments that harness the power of the immune system.
Collaborations
Throughout her career, Anfonso has collaborated with talented professionals such as Diogo Antonio Remechido Anjos and Daniel Vargas Correia. These partnerships focus on advancing the field of lymphocyte technology, showcasing the importance of teamwork in scientific innovation.
Conclusion
Anfonso Rocha Martins De Almeida stands out as an inspiring inventor in the realm of modern medicine. Her dedication to advancing T cell production techniques illustrates the transformative potential of her work. As she continues her journey in the field, her contributions will undoubtedly pave the way for future innovations in immunotherapy.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile